Registration, quality assurance and the shape of a medicines contract
A medicines tender is decided on quality assurance before it is decided on price. Bidders must show that the product is authorised or registered for use in the destination market, that it is manufactured at a site holding current good manufacturing practice certification, and -- for many donor-funded and essential medicines programmes -- that the product or its manufacturer appears on a recognised prequalification list. These are documentary conditions of admissibility assessed against the specific product and manufacturing site offered, and a change of site after award is a contractual event, not an administrative one.
Products are specified by international non-proprietary name, strength and dosage form so that generics compete openly, with pharmacopoeial standards cited for quality. Delivery conditions carry as much weight as the product: a minimum proportion of shelf life remaining on arrival, batch certificates of analysis, tamper-evident and correctly labelled packaging in the required language, and unbroken cold chain with temperature monitoring for products that need it. A consignment that arrives with too little shelf life left is routinely rejected at the buyer's cost to the supplier.
The commercial structure is usually a framework at agreed unit prices with call-offs against forecast rather than firm volume, because demand depends on disease patterns and programme funding. That places emphasis on lead times, on the supplier's obligation to hold or replenish stock, and on what happens in a shortage -- allocation, substitution and notification terms are increasingly explicit. Recall capability is tested rather than assumed: buyers ask how quickly a batch can be traced and withdrawn from every facility it reached.
This section describes how this category is bought generally, across the public buyers that publish it. The figures elsewhere on this page are measured for this market alone.
Who buys pharmaceuticals in Ukraine?
GlobalGov holds 247 pharmaceuticals records from 165 distinct buying organisations in Ukraine. The most frequent publishers are International buyer (12 records); International buyer (7 records); International buyer (4 records); World Bank -- Ukraine Improving Higher Education For Results Project (3 records); International buyer (3 records); International buyer (3 records). Between them the 6 largest account for 13% of everything published, so buying here is spread across many separate authorities.
| Buying organisation | Records | Share |
|---|---|---|
| International buyer | 12 | 4.9% |
| International buyer | 7 | 2.8% |
| International buyer | 4 | 1.6% |
| World Bank -- Ukraine Improving Higher Education For Results Project | 3 | 1.2% |
| International buyer | 3 | 1.2% |
| International buyer | 3 | 1.2% |
What are pharmaceuticals contracts worth in Ukraine?
244 of the 247 records publish a contract value. The median is $4,116 and the largest single published value is $1.5M. By size, 236 under $100k, 6 between $100k and $1M, 2 between $1M and $10M. The remaining 3 publish no value at all, so every figure here describes the priced subset only, and values are as stated by the buyer rather than as finally awarded.
| Contract size | Records | Share of priced |
|---|---|---|
| under $100k | 236 | 97% |
| between $100k and $1M | 6 | 2.5% |
| between $1M and $10M | 2 | 0.8% |
| above $10M | 0 | 0.0% |
How long do bidders get to respond to pharmaceuticals tenders in Ukraine?
Across the 46 Ukraine pharmaceuticals notices that publish both a publication date and a closing date, the median response window is 5 days. A quarter of them allowed 4 days or fewer and a quarter stayed open for more than 7. 42 of them (91%) closed within a fortnight of being published, so on this market a bidder who reviews notices once a week can lose most of the response window before reading one.
How often are pharmaceuticals tenders published in Ukraine?
Ukraine publishes about 21 notices a month in this category, 247 in the last twelve months. Over the last three years there were 247, spread across 4 separate months of activity since 2 April 2026. April is historically the busiest month. The most recent was published 23 August 2026.
Where do the Ukraine pharmaceuticals records on this page come from?
These 247 records are collected from 2 official sources: Prozorro (244), the World Bank (3). GlobalGov is an independent aggregator and is not affiliated with any of them; each record links back to the notice on its issuing portal. The set is rebuilt nightly, and the counts on this page were taken on 2026-10-01.
Most recent Pharmaceuticals tenders in Ukraine
None of these are open for bids now — they are the most recent records GlobalGov holds for this market, kept here so the shape of a typical pharmaceuticals notice in Ukraine is visible. Set an alert to be told when the next one opens.
DK 021:2015 33790000-4 - Glassware for laboratory, sanitary and hygienic or pharmaceutical purposes (33793000-5 Glassware for laboratory purposes"NK031-2024 - W0503040104 W0503030101)
Pharmaceutical products code 33600000-6 according to DK 021:2015 "Unified Procurement Dictionary" (Anidulafungin - code 33650000-1 according to DK 021:2015 General anti-infectives for systemic use, vaccines, antineoplastic agents and immunomodulators)
DK 021:2015-33600000-6 Pharmaceutical products (Various medicines)
Procurement of a Robotic Welding Cell for Stepan Gzhytskyi National University of Veterinary Medicine and Biotechnologies Lviv and Admiral Makarov National University of Shipbuilding
Pharmaceutical products in the assortment (Hydrogen peroxide solution 3% 100ml Ternofarm, Mint tablets 500mg No. 10 Farmakom, Ranitidine Euro tab. 150mg No. 100(10*10) Unique Pharmaceutical, Loperamide tab. 2mg No. 20 Marifarm, Ethanol 96% fl. 100ml Kilaff (pack=50fl.) Plas., Iodine alcohol solution 5% 20ml Ternofarm 50/pack, Analgin tab. 500mg No. 10 Darnytsia, Belastezin tab. 10 60/pack, Validol-Darnytsia tab. 60mg No. 10, Drotaverin tab. 40mg No. 20 Chervona zirka, Kaptopres tab. 50mg +25mg pack. No. 20 Darnytsia, Captopril 25 mg tab. No. 20 KMP, Loratady
33690000-3 Miscellaneous medicinal products (APTT liquid test (100 tests) (NK031:2024 - Code EMDN W0103020102-ACTIVATED PARTIAL THROMBOPLASTIN TIME) (NK 024:2023 55981-Activated partial thromboplastin time IVD (in vitro diagnostics), kit, clot formation analysis), PC test with liquid reagent (400 tests) (NK031:2024 - Code EMDN W0103020202- COAGULATION FACTOR II (PROTHROMBIN)) (NK 024: 55983-Prothrombin time (PT) IVD (in vitro diagnostics), kit, clot formation analysis), Thrombo-test (400 tests)
Laboratory reagents
"Code DK 021:2015: 33690000-3 Miscellaneous medicinal products (Reagents for clinical diagnostic laboratory for reagents for immunofluorescence analyzer LS-1100 (code NK 024:2023 44435-Control material for the determination of glycated hemoglobin (HbA1c), IVD (in vitro diagnostics), 54313-Procalcitonin IVD (in vitro diagnostics), kit, immunofluorescence analysis, 54315-Procalcitonin IVD (in vitro diagnostics), control material, 62206-Glycosylated hemoglobin (HbA1c) monitoring system for
Miscellaneous laboratory reagents, code DK 021:2015:33690000-3 - Miscellaneous medicinal products (33696000-5 Reagents and contrast agents)
Other procurement categories in Ukraine
Pharmaceuticals procurement in other markets
Never Miss a Ukraine Government Contract
Finding Ukraine tenders usually means a local portal, a local registration and someone who reads the language. Get an alert you can read when a new pharmaceuticals opportunity is published there.
Start Free Trial